TARGETING THE TLK1/NEK1 AXIS IN PROSTATE CANCER

• 收藏
• 分享

专利权人:

Board of Supervisors of Louisiana State University and Agricultural and Mechanical College

发明人:

Arrigo DeBENEDETTI,Siddhant BHOIR,Vibha SINGH,Javeena HUSSAIN,Rupesh CHIKHALE,Richard BRYCE,Sivapriya KIRUBAKARAN

申请号：

US16834061

公开号：

US20200306258A1

申请日:

2020.03.30

申请国别(地区):

US

年份:

2020

代理人:

摘要：

A method of treating prostate cancer in a patient comprising administering to the patient a pharmaceutical composition including a first therapeutic including a TLK1B inhibitor, or a pharmaceutically acceptable salt, solvate, ester, amide, clathrate, stereoisomer, enantiomer, prodrug or analog thereof, and a second therapeutic including an antiandrogen or a pharmaceutically acceptable salt, solvate, ester, amide, clathrate, stereoisomer, enantiomer, prodrug or analog thereof.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/